Shuhei Sakaguchi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Shuhei Sakaguchi has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Shinobu Furusawa
Cancer Research Institute, Tohoku Pharmaceutical University, 4‐4‐1 Komatsushima, Aoba‐ku, Sendai 981‐8558, Japan
11 shared publicationsMotoaki Takayanagi
Cancer Research Institute, Tohoku Pharmaceutical University, 4‐4‐1 Komatsushima, Aoba‐ku, Sendai 981‐8558, Japan
7 shared publicationsYukisumi Iizuka
First Department of Pharmaceutics, and
5 shared publicationsSusumu Satoh
Cancer Research Institute, Tohoku Pharmaceutical University, 4‐4‐1 Komatsushima, Aoba‐ku, Sendai 981‐8558, Japan
4 shared publicationsKatsushi Yokota
3 shared publicationsKen-Ichi Sasaki
3 shared publications
Latest Publications
- 1 January 2011
- Published by Japanese Society for the Study of Xenobiotics in Drug Metabolism and Pharmacokinetics
- Vol. 26 (1) , 30-46
Progression of Alcoholic and Non-alcoholic Steatohepatitis: Common Metabolic Aspects of Innate Immune System and Oxidative Stress
Growing evidence indicates that the innate immune system and oxidative stress caused by gut-derived endotoxins play a key role in alcoholic liver disease (ALD). Intracellular mechanisms associated with endotoxin-induced signaling play a crucial role in the initiation and progression of ALD. It is now widely accepted that activation of the innate immune system and increased release of pro-inflammatory cytokines and other mediators play an important role in the development of ALD. Accumulating evidence suggests that alcohol-mediated upregulation of CYP2E1 expression may initiate lipid peroxidation via reactive oxygen species. Non-alcoholic steatohepatitis (NASH) is a liver disease characterized by histopathological features similar to those observed in ALD, but in the absence of significant alcohol consumption. Initial efforts to clarify the mechanisms that promote the progression from steatosis to steatohepatitis somewhat artificially divided disease mechanisms into "first and second hits." This model considered the development of steatosis to be the "first hit," increasing the sensitivity of the liver to the putative "second hit," leading to hepatocyte injury, inflammation, and oxidative stress. We have emphasized the important role of gut-derived bacterial toxins, the innate immune system, and oxidative stress in the common pathogenic mechanism in ALD and NASH progression.
- 1 January 2011
- Published by Japanese Society for the Study of Xenobiotics in Drug Metabolism and Pharmacokinetics
- Vol. 26 (1) , 30-46
Progression of Alcoholic and Non-alcoholic Steatohepatitis: Common Metabolic Aspects of Innate Immune System and Oxidative Stress
Growing evidence indicates that the innate immune system and oxidative stress caused by gut-derived endotoxins play a key role in alcoholic liver disease (ALD). Intracellular mechanisms associated with endotoxin-induced signaling play a crucial role in the initiation and progression of ALD. It is now widely accepted that activation of the innate immune system and increased release of pro-inflammatory cytokines and other mediators play an important role in the development of ALD. Accumulating evidence suggests that alcohol-mediated upregulation of CYP2E1 expression may initiate lipid peroxidation via reactive oxygen species. Non-alcoholic steatohepatitis (NASH) is a liver disease characterized by histopathological features similar to those observed in ALD, but in the absence of significant alcohol consumption. Initial efforts to clarify the mechanisms that promote the progression from steatosis to steatohepatitis somewhat artificially divided disease mechanisms into "first and second hits." This model considered the development of steatosis to be the "first hit," increasing the sensitivity of the liver to the putative "second hit," leading to hepatocyte injury, inflammation, and oxidative stress. We have emphasized the important role of gut-derived bacterial toxins, the innate immune system, and oxidative stress in the common pathogenic mechanism in ALD and NASH progression.
- 7 July 2008
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 89 (5) , 273-276
Haem Metabolic Aspects on Nitric Oxide Formation in Endotoxaemia
- 7 July 2008
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 89 (5) , 273-276
Haem Metabolic Aspects on Nitric Oxide Formation in Endotoxaemia
- 28 February 2007
- Published by Elsevier in International Immunopharmacology
- Vol. 7 (2) , 191-197
Preventive effects of a biscoclaurine alkaloid, cepharanthine, on endotoxin or tumor necrosis factor-α-induced septic shock symptoms: Involvement of from cell death in L929 cells and nitric oxide production in raw 264.7 cells
- 28 February 2007
- Published by Elsevier in International Immunopharmacology
- Vol. 7 (2) , 191-197
Preventive effects of a biscoclaurine alkaloid, cepharanthine, on endotoxin or tumor necrosis factor-α-induced septic shock symptoms: Involvement of from cell death in L929 cells and nitric oxide production in raw 264.7 cells
- Open Access
- 1 July 2006
- Published by Oxford University Press (OUP) in FEMS Immunology & Medical Microbiology
- Vol. 47 (2) , 167-177
Oxidative stress and septic shock: metabolic aspects of oxygen-derived free radicals generated in the liver during endotoxemia
This review describes the role of oxidative stress caused by endotoxin challenge in sepsis or septic shock symptoms. We observed that endotoxin injec
- 1 July 2006
- Published by Oxford University Press (OUP) in FEMS Immunology & Medical Microbiology
- Vol. 47 (2) , 167-177
Open AccessOxidative stress and septic shock: metabolic aspects of oxygen-derived free radicals generated in the liver during endotoxemia
This review describes the role of oxidative stress caused by endotoxin challenge in sepsis or septic shock symptoms. We observed that endotoxin injec
- 1 January 2005
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 28 (1) , 165-168
Preventive Effects of a Traditional Chinese Medicine (Sho-saiko-to) on Septic Shock Symptoms; Approached from Heme Metabolic Disorders in Endotoxemia
Sho-saiko-to, one of the the most frequently prescribed Kampo medicines, is used to treat chronic hepatitis and has shown confirmed clinical efficacy. The present study was performed with respect to heme metabolism to study the preventive effects of Sho-saiko-to against endotoxemia. Endotoxin was injected intraperitoneally at a dose of 6 mg/kg into Sho-saiko-to (500 mg/kg/d, p.o.)-pretreated rats, and its administration clearly prevented the endotoxin-induced hypoferremia. In rats pretreated with Sho-saiko-to, the activity of hepatic delta-aminolevulinate synthetase and cytochrome P-450 level 18 h after endotoxin injection were significantly increased as compared to rats treated with endotoxin alone. Similarly, Sho-saiko-to significantly depressed the endotoxin-induced increase in heme oxygenase activity in liver microsomes. These findings suggested that the extent of shock syndrome caused by endotoxin may be due, at least in part, to changes in heme metabolic disturbance during endotoxemia. Sho-saiko-to may therefore protect rats against lethality caused by endotoxin through its ability to regulate the heme metabolism in septic shock.
- 1 January 2005
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 28 (1) , 165-168
Preventive Effects of a Traditional Chinese Medicine (Sho-saiko-to) on Septic Shock Symptoms; Approached from Heme Metabolic Disorders in Endotoxemia
Sho-saiko-to, one of the the most frequently prescribed Kampo medicines, is used to treat chronic hepatitis and has shown confirmed clinical efficacy. The present study was performed with respect to heme metabolism to study the preventive effects of Sho-saiko-to against endotoxemia. Endotoxin was injected intraperitoneally at a dose of 6 mg/kg into Sho-saiko-to (500 mg/kg/d, p.o.)-pretreated rats, and its administration clearly prevented the endotoxin-induced hypoferremia. In rats pretreated with Sho-saiko-to, the activity of hepatic delta-aminolevulinate synthetase and cytochrome P-450 level 18 h after endotoxin injection were significantly increased as compared to rats treated with endotoxin alone. Similarly, Sho-saiko-to significantly depressed the endotoxin-induced increase in heme oxygenase activity in liver microsomes. These findings suggested that the extent of shock syndrome caused by endotoxin may be due, at least in part, to changes in heme metabolic disturbance during endotoxemia. Sho-saiko-to may therefore protect rats against lethality caused by endotoxin through its ability to regulate the heme metabolism in septic shock.
- 1 February 2004
- Published by Pharmaceutical Society of Japan in YAKUGAKU ZASSHI
- Vol. 124 (2) , 69-87
Metabolic Aspects of Endotoxin as a Model of Septic Shock —Approached from Oxidative Stress—
Despite the remarkable progress in intensive care medicine, sepsis and shock continue to be major clinical problems in intensive care units. Septic shock may be associated with a toxic state initiated by the stimulation of monocytes by bacterial toxins such as endotoxin, which is released into the bloodstream. This study describes the role of oxidative stress in endotoxin-induced metabolic disorders. We demonstrate that endotoxin injection results in lipid peroxide formation and membrane injury in experimental animals, causing decreased levels of free radical scavengers or quenchers. Interestingly, it was also suggested that tumor necrosis factor (TNF)-induced oxidative stress occurs as a result of bacterial or endotoxin translocation under conditions of reduced reticuloendothelial system function in various disease states. In addition, we suggest that intracellular Ca2+, Zn2+, or selenium levels may participate, at least in part, in the oxidative stress during endotoxemia. On the other hand, it is also suggested that the extent of endotoxin-induced nitric oxide (NO) formation may be due, at least in part, to a change in heme metabolic regulation during endotoxemia. However, in our experimental model, NO is not crucial for lipid peroxide formation during endotoxemia. Sho-saiko-to is one of the most frequently prescribed Kampo medicines and has primarily been used to treat chronic hepatitis. We report that Sho-saiko-to decreases the rh TNF-induced lethality in galactosamine-hypersensitized mice and protects mice against oxygen toxicity and Ca2+ overload in the cytoplasm or mitochondria during endotoxemia. We further suggest that Sho-saiko-to shows a suppressive effect on NO generation in macrophages stimulated with endotoxin and that it may be useful in improving endotoxin shock symptoms.
- 1 February 2004
- Published by Pharmaceutical Society of Japan in YAKUGAKU ZASSHI
- Vol. 124 (2) , 69-87
Metabolic Aspects of Endotoxin as a Model of Septic Shock —Approached from Oxidative Stress—
Despite the remarkable progress in intensive care medicine, sepsis and shock continue to be major clinical problems in intensive care units. Septic shock may be associated with a toxic state initiated by the stimulation of monocytes by bacterial toxins such as endotoxin, which is released into the bloodstream. This study describes the role of oxidative stress in endotoxin-induced metabolic disorders. We demonstrate that endotoxin injection results in lipid peroxide formation and membrane injury in experimental animals, causing decreased levels of free radical scavengers or quenchers. Interestingly, it was also suggested that tumor necrosis factor (TNF)-induced oxidative stress occurs as a result of bacterial or endotoxin translocation under conditions of reduced reticuloendothelial system function in various disease states. In addition, we suggest that intracellular Ca2+, Zn2+, or selenium levels may participate, at least in part, in the oxidative stress during endotoxemia. On the other hand, it is also suggested that the extent of endotoxin-induced nitric oxide (NO) formation may be due, at least in part, to a change in heme metabolic regulation during endotoxemia. However, in our experimental model, NO is not crucial for lipid peroxide formation during endotoxemia. Sho-saiko-to is one of the most frequently prescribed Kampo medicines and has primarily been used to treat chronic hepatitis. We report that Sho-saiko-to decreases the rh TNF-induced lethality in galactosamine-hypersensitized mice and protects mice against oxygen toxicity and Ca2+ overload in the cytoplasm or mitochondria during endotoxemia. We further suggest that Sho-saiko-to shows a suppressive effect on NO generation in macrophages stimulated with endotoxin and that it may be useful in improving endotoxin shock symptoms.
- 1 January 2004
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 27 (9) , 1468-1470
Preventive Effects of a Traditional Chinese Medicine (Sho-saiko-to) on Endotoxin-Induced Cytotoxicity and Tumor Necrosis Factor-.ALPHA. Production in J774A.1 Cells
Sho-saiko-to, one of the most frequently prescribed Kampo medicines, is used clinically to treat chronic hepatitis and has shown confirmed clinical efficacy. The present study investigated whether Sho-saiko-to can suppress cytotoxicity and tumor necrosis factor (TNF)-alpha production in endotoxin-treated J774A.1 cells. Sho-saiko-to (10-20 microg/ml) did not affect the proliferation of J774A.1 cells, while a high concentration (50 microg/ml) of Sho-saiko-to induced a slight reduction in cell viability. Treatment with Sho-saiko-to (10-50 microg/ml) significantly inhibited endotoxin (10 microg/ml)-induced cytotoxicity in J774A.1 cells. In addition, Sho-saiko-to (20 microg/ml) suppressed TNF-alpha production by endotoxin (1 microg/ml)-activated J774A.1 cells. These findings suggest that the Kampo prescription Sho-saiko-to suppresses cytotoxicity or TNF-alpha production in macrophages treated with endotoxin and that it may be useful in improving septic shock symptoms. Sho-saiko-to may therefore protect against some of the various disturbances caused by endotoxins through its ability to inhibit TNF-alpha production in septic shock.
- 1 January 2004
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 27 (9) , 1468-1470
Preventive Effects of a Traditional Chinese Medicine (Sho-saiko-to) on Endotoxin-Induced Cytotoxicity and Tumor Necrosis Factor-.ALPHA. Production in J774A.1 Cells
Sho-saiko-to, one of the most frequently prescribed Kampo medicines, is used clinically to treat chronic hepatitis and has shown confirmed clinical efficacy. The present study investigated whether Sho-saiko-to can suppress cytotoxicity and tumor necrosis factor (TNF)-alpha production in endotoxin-treated J774A.1 cells. Sho-saiko-to (10-20 microg/ml) did not affect the proliferation of J774A.1 cells, while a high concentration (50 microg/ml) of Sho-saiko-to induced a slight reduction in cell viability. Treatment with Sho-saiko-to (10-50 microg/ml) significantly inhibited endotoxin (10 microg/ml)-induced cytotoxicity in J774A.1 cells. In addition, Sho-saiko-to (20 microg/ml) suppressed TNF-alpha production by endotoxin (1 microg/ml)-activated J774A.1 cells. These findings suggest that the Kampo prescription Sho-saiko-to suppresses cytotoxicity or TNF-alpha production in macrophages treated with endotoxin and that it may be useful in improving septic shock symptoms. Sho-saiko-to may therefore protect against some of the various disturbances caused by endotoxins through its ability to inhibit TNF-alpha production in septic shock.
- 1 September 2002
- Published by Elsevier in European Journal of Pharmacology
- Vol. 451 (3) , 309-316
Role of Zn2+ in oxidative stress caused by endotoxin challenge
- 1 September 2002
- Published by Elsevier in European Journal of Pharmacology
- Vol. 451 (3) , 309-316
Role of Zn2+ in oxidative stress caused by endotoxin challenge
- 6 May 2002
- Published by Elsevier in International Immunopharmacology
- Vol. 2 (7) , 867-873
Preventive effects of a verapamil against tumor necrosis factor-alpha-induced shock symptoms: approached from lipoprotein metabolic disorders
- 6 May 2002
- Published by Elsevier in International Immunopharmacology
- Vol. 2 (7) , 867-873
Preventive effects of a verapamil against tumor necrosis factor-alpha-induced shock symptoms: approached from lipoprotein metabolic disorders
- 1 November 2001
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 89 (5) , 273-276
Haem Metabolic Aspects on Nitric Oxide Formation in Endotoxaemia
- 1 November 2001
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 89 (5) , 273-276
Haem Metabolic Aspects on Nitric Oxide Formation in Endotoxaemia